Skip to main content
. 2022 Jun 30;17:2883–2890. doi: 10.2147/IJN.S367721

Figure 3.

Figure 3

In vivo PA and MR imaging studies of TDMVs+MNP-Gd. (A) PA images in the tumor region collected by using the MOST imaging system before (pre) and at various time points after injection of TDMVs+MNP-Gd. (B) T1-Weighted MR axial images of tumor-bearing mice before (pre) and at various time points after injection of TDMVs+MNP-Gd using 3.0 T clinical MRI equipment. The yellow circles point to the tumor sites.